| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 125 | 2026 | 1428 | 19.670 |
Why?
|
| Vaccines | 39 | 2026 | 390 | 10.810 |
Why?
|
| Papillomavirus Vaccines | 37 | 2026 | 298 | 8.380 |
Why?
|
| Influenza Vaccines | 44 | 2026 | 532 | 8.290 |
Why?
|
| Immunization | 29 | 2025 | 374 | 5.960 |
Why?
|
| Parents | 41 | 2026 | 1404 | 5.570 |
Why?
|
| Health Knowledge, Attitudes, Practice | 41 | 2025 | 1420 | 5.370 |
Why?
|
| Influenza, Human | 27 | 2026 | 617 | 5.290 |
Why?
|
| Papillomavirus Infections | 23 | 2026 | 346 | 5.010 |
Why?
|
| Immunization Programs | 15 | 2025 | 194 | 4.650 |
Why?
|
| Motivational Interviewing | 12 | 2025 | 121 | 4.500 |
Why?
|
| Vaccination Refusal | 14 | 2022 | 64 | 4.380 |
Why?
|
| Obstetrics | 14 | 2022 | 175 | 4.170 |
Why?
|
| Gynecology | 13 | 2022 | 178 | 3.930 |
Why?
|
| Attitude of Health Personnel | 32 | 2026 | 1196 | 3.630 |
Why?
|
| Patient Acceptance of Health Care | 26 | 2025 | 887 | 3.460 |
Why?
|
| Practice Patterns, Physicians' | 25 | 2024 | 1358 | 3.250 |
Why?
|
| Advisory Committees | 20 | 2025 | 230 | 3.130 |
Why?
|
| Immunization Schedule | 22 | 2025 | 188 | 3.060 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 92 | 3.040 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 9 | 2025 | 39 | 2.920 |
Why?
|
| Vaccination Coverage | 11 | 2026 | 104 | 2.870 |
Why?
|
| Meningococcal Vaccines | 13 | 2025 | 58 | 2.840 |
Why?
|
| Pregnancy Complications, Infectious | 8 | 2023 | 429 | 2.600 |
Why?
|
| Narration | 3 | 2026 | 75 | 2.500 |
Why?
|
| Humans | 267 | 2026 | 145305 | 2.490 |
Why?
|
| Child | 94 | 2026 | 22712 | 2.480 |
Why?
|
| Clergy | 4 | 2020 | 10 | 2.430 |
Why?
|
| Physicians, Primary Care | 12 | 2024 | 208 | 2.410 |
Why?
|
| Colorado | 43 | 2026 | 4579 | 2.370 |
Why?
|
| Communication | 16 | 2026 | 973 | 2.200 |
Why?
|
| Health Personnel | 14 | 2024 | 748 | 2.180 |
Why?
|
| Neurosurgical Procedures | 8 | 2026 | 202 | 2.170 |
Why?
|
| Caregivers | 5 | 2026 | 1056 | 2.020 |
Why?
|
| Hepatitis B | 4 | 2023 | 66 | 2.020 |
Why?
|
| Pediatrics | 17 | 2026 | 1118 | 1.950 |
Why?
|
| Female | 159 | 2026 | 78605 | 1.930 |
Why?
|
| Infant | 55 | 2026 | 10101 | 1.870 |
Why?
|
| Pediatricians | 9 | 2024 | 121 | 1.800 |
Why?
|
| Religion | 3 | 2020 | 65 | 1.790 |
Why?
|
| Health Communication | 4 | 2021 | 54 | 1.780 |
Why?
|
| Viral Vaccines | 4 | 2024 | 107 | 1.780 |
Why?
|
| Pregnancy | 48 | 2026 | 7208 | 1.760 |
Why?
|
| Whooping Cough | 6 | 2022 | 55 | 1.660 |
Why?
|
| Adult | 92 | 2026 | 40627 | 1.660 |
Why?
|
| Attitude to Health | 9 | 2020 | 436 | 1.640 |
Why?
|
| United States | 62 | 2026 | 16051 | 1.630 |
Why?
|
| Reminder Systems | 5 | 2026 | 141 | 1.610 |
Why?
|
| Adolescent | 71 | 2026 | 22507 | 1.610 |
Why?
|
| Respiratory Syncytial Virus Infections | 6 | 2025 | 136 | 1.550 |
Why?
|
| Male | 112 | 2026 | 72628 | 1.430 |
Why?
|
| Physician-Patient Relations | 6 | 2026 | 588 | 1.400 |
Why?
|
| Emergency Service, Hospital | 5 | 2025 | 2328 | 1.330 |
Why?
|
| Brain Neoplasms | 5 | 2026 | 1327 | 1.290 |
Why?
|
| Social Media | 4 | 2021 | 171 | 1.240 |
Why?
|
| Treatment Refusal | 5 | 2020 | 98 | 1.240 |
Why?
|
| Primary Health Care | 14 | 2024 | 1737 | 1.200 |
Why?
|
| Child, Preschool | 37 | 2026 | 11863 | 1.200 |
Why?
|
| Suicide | 3 | 2025 | 726 | 1.170 |
Why?
|
| Surveys and Questionnaires | 34 | 2025 | 6079 | 1.170 |
Why?
|
| Physicians, Family | 10 | 2021 | 173 | 1.110 |
Why?
|
| Health Promotion | 5 | 2020 | 777 | 1.100 |
Why?
|
| Adolescent Health Services | 4 | 2015 | 75 | 1.080 |
Why?
|
| Pseudotumor Cerebri | 2 | 2025 | 32 | 1.070 |
Why?
|
| Mass Screening | 3 | 2025 | 1357 | 1.070 |
Why?
|
| Middle Aged | 59 | 2026 | 36021 | 1.060 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 6 | 2024 | 193 | 1.030 |
Why?
|
| Safety-net Providers | 3 | 2025 | 131 | 0.980 |
Why?
|
| Measles | 4 | 2022 | 46 | 0.960 |
Why?
|
| Trust | 5 | 2026 | 155 | 0.960 |
Why?
|
| Prenatal Care | 2 | 2020 | 307 | 0.960 |
Why?
|
| Qualitative Research | 12 | 2025 | 1681 | 0.960 |
Why?
|
| Practice Guidelines as Topic | 12 | 2025 | 1568 | 0.920 |
Why?
|
| Spinal Cord | 2 | 2025 | 383 | 0.920 |
Why?
|
| Physicians | 11 | 2022 | 950 | 0.910 |
Why?
|
| Diphtheria | 4 | 2022 | 21 | 0.910 |
Why?
|
| Tetanus | 4 | 2022 | 26 | 0.900 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2025 | 27 | 0.900 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 3 | 2022 | 47 | 0.900 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2023 | 193 | 0.900 |
Why?
|
| Patient Outcome Assessment | 2 | 2019 | 134 | 0.900 |
Why?
|
| Stereotaxic Techniques | 1 | 2025 | 42 | 0.890 |
Why?
|
| Rural Health Services | 2 | 2024 | 141 | 0.890 |
Why?
|
| Radiosurgery | 2 | 2026 | 401 | 0.890 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2025 | 81 | 0.880 |
Why?
|
| Knee Prosthesis | 1 | 2025 | 29 | 0.880 |
Why?
|
| Health Care Surveys | 12 | 2021 | 539 | 0.870 |
Why?
|
| Policy | 3 | 2020 | 147 | 0.870 |
Why?
|
| Glioma | 2 | 2026 | 427 | 0.860 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2024 | 2 | 0.860 |
Why?
|
| Prosthesis Failure | 1 | 2025 | 128 | 0.850 |
Why?
|
| Immunotherapy | 2 | 2026 | 660 | 0.840 |
Why?
|
| Preventive Health Services | 3 | 2025 | 154 | 0.840 |
Why?
|
| Pandemics | 6 | 2024 | 1698 | 0.840 |
Why?
|
| Spinal Dysraphism | 1 | 2026 | 114 | 0.830 |
Why?
|
| Orbital Diseases | 1 | 2024 | 35 | 0.830 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 264 | 0.820 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2024 | 71 | 0.810 |
Why?
|
| Community Participation | 2 | 2025 | 132 | 0.810 |
Why?
|
| Osteomyelitis | 2 | 2024 | 143 | 0.800 |
Why?
|
| Anterior Cruciate Ligament Injuries | 5 | 2024 | 217 | 0.790 |
Why?
|
| Laser Therapy | 1 | 2025 | 135 | 0.780 |
Why?
|
| Schools | 3 | 2025 | 453 | 0.770 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2025 | 372 | 0.760 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2025 | 175 | 0.750 |
Why?
|
| Religion and Medicine | 2 | 2019 | 33 | 0.740 |
Why?
|
| Ambulatory Care | 4 | 2020 | 603 | 0.740 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 328 | 0.730 |
Why?
|
| Developing Countries | 1 | 2024 | 319 | 0.730 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 529 | 0.710 |
Why?
|
| Health Equity | 1 | 2024 | 129 | 0.710 |
Why?
|
| Health Services Research | 4 | 2019 | 396 | 0.710 |
Why?
|
| Young Adult | 28 | 2026 | 14163 | 0.700 |
Why?
|
| Hepatitis B Vaccines | 4 | 2023 | 43 | 0.700 |
Why?
|
| Arachnoid Cysts | 3 | 2026 | 10 | 0.700 |
Why?
|
| Refusal to Treat | 2 | 2020 | 16 | 0.690 |
Why?
|
| Infant, Newborn | 17 | 2025 | 6456 | 0.690 |
Why?
|
| Suicide, Attempted | 1 | 2025 | 422 | 0.690 |
Why?
|
| Cochlear Implantation | 1 | 2022 | 82 | 0.680 |
Why?
|
| Urban Population | 4 | 2024 | 495 | 0.680 |
Why?
|
| Herpes Zoster Vaccine | 6 | 2022 | 154 | 0.680 |
Why?
|
| Cochlear Implants | 1 | 2022 | 95 | 0.680 |
Why?
|
| Global Health | 1 | 2024 | 403 | 0.670 |
Why?
|
| Arthritis, Infectious | 1 | 2022 | 72 | 0.670 |
Why?
|
| Private Practice | 1 | 2020 | 19 | 0.660 |
Why?
|
| Pneumococcal Vaccines | 6 | 2021 | 130 | 0.660 |
Why?
|
| Rural Population | 6 | 2024 | 657 | 0.660 |
Why?
|
| Standing Orders | 2 | 2020 | 10 | 0.650 |
Why?
|
| Streptococcal Vaccines | 2 | 2025 | 7 | 0.650 |
Why?
|
| Lipids | 1 | 2025 | 712 | 0.650 |
Why?
|
| School Health Services | 4 | 2026 | 224 | 0.650 |
Why?
|
| Retrospective Studies | 30 | 2026 | 17149 | 0.640 |
Why?
|
| Professional-Patient Relations | 3 | 2018 | 154 | 0.640 |
Why?
|
| Burns | 1 | 2025 | 377 | 0.640 |
Why?
|
| Myocarditis | 1 | 2021 | 102 | 0.630 |
Why?
|
| Anti-Vaccination Movement | 1 | 2019 | 3 | 0.620 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 84 | 0.610 |
Why?
|
| Longevity | 1 | 2021 | 174 | 0.610 |
Why?
|
| Freedom | 1 | 2019 | 15 | 0.610 |
Why?
|
| Health Care Costs | 3 | 2020 | 427 | 0.600 |
Why?
|
| Text Messaging | 3 | 2019 | 184 | 0.600 |
Why?
|
| Registries | 5 | 2025 | 2398 | 0.590 |
Why?
|
| Treatment Outcome | 17 | 2026 | 11731 | 0.590 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 5883 | 0.590 |
Why?
|
| Public Health | 4 | 2024 | 566 | 0.580 |
Why?
|
| Chickenpox Vaccine | 3 | 2017 | 75 | 0.580 |
Why?
|
| Hearing Loss | 1 | 2022 | 248 | 0.570 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 736 | 0.570 |
Why?
|
| Disease Outbreaks | 3 | 2022 | 422 | 0.560 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 157 | 0.560 |
Why?
|
| Rotavirus Infections | 2 | 2021 | 36 | 0.550 |
Why?
|
| Rotavirus Vaccines | 2 | 2021 | 38 | 0.550 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2024 | 453 | 0.550 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 38 | 0.540 |
Why?
|
| Patient-Centered Care | 3 | 2026 | 546 | 0.540 |
Why?
|
| Streptococcal Infections | 2 | 2025 | 169 | 0.540 |
Why?
|
| Down Syndrome | 2 | 2021 | 534 | 0.530 |
Why?
|
| Mothers | 5 | 2022 | 776 | 0.530 |
Why?
|
| Documentation | 2 | 2019 | 199 | 0.520 |
Why?
|
| Patient Preference | 2 | 2017 | 226 | 0.520 |
Why?
|
| Aged | 29 | 2026 | 26001 | 0.520 |
Why?
|
| Hepatitis A Vaccines | 4 | 2019 | 20 | 0.520 |
Why?
|
| Infertility | 3 | 2023 | 55 | 0.510 |
Why?
|
| Neuroendoscopy | 3 | 2025 | 24 | 0.500 |
Why?
|
| Cues | 1 | 2019 | 326 | 0.500 |
Why?
|
| Propensity Score | 4 | 2026 | 370 | 0.490 |
Why?
|
| Mass Media | 1 | 2016 | 41 | 0.490 |
Why?
|
| Physician's Role | 2 | 2019 | 220 | 0.490 |
Why?
|
| Evidence-Based Medicine | 5 | 2024 | 737 | 0.490 |
Why?
|
| Interviews as Topic | 6 | 2025 | 907 | 0.480 |
Why?
|
| Mumps | 3 | 2022 | 22 | 0.480 |
Why?
|
| Health Education | 2 | 2018 | 358 | 0.470 |
Why?
|
| Cranial Fossa, Middle | 2 | 2026 | 19 | 0.470 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 947 | 0.460 |
Why?
|
| Health Policy | 2 | 2025 | 401 | 0.450 |
Why?
|
| Vaccines, Combined | 4 | 2023 | 49 | 0.450 |
Why?
|
| Cost-Benefit Analysis | 4 | 2024 | 639 | 0.440 |
Why?
|
| Computers, Handheld | 1 | 2015 | 26 | 0.440 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 270 | 0.430 |
Why?
|
| Dengue Vaccines | 3 | 2019 | 11 | 0.420 |
Why?
|
| Anthrax Vaccines | 3 | 2018 | 7 | 0.420 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2023 | 17 | 0.400 |
Why?
|
| Recovery of Function | 2 | 2020 | 714 | 0.390 |
Why?
|
| United Kingdom | 6 | 2025 | 338 | 0.380 |
Why?
|
| Internet | 5 | 2019 | 701 | 0.380 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 8295 | 0.380 |
Why?
|
| Age Factors | 7 | 2026 | 3339 | 0.380 |
Why?
|
| Seizures, Febrile | 1 | 2012 | 23 | 0.370 |
Why?
|
| Washington | 2 | 2025 | 147 | 0.370 |
Why?
|
| Meningococcal Infections | 3 | 2018 | 26 | 0.370 |
Why?
|
| Herpes Zoster | 3 | 2022 | 315 | 0.360 |
Why?
|
| Nurseries, Hospital | 1 | 2012 | 5 | 0.360 |
Why?
|
| Safety | 2 | 2020 | 356 | 0.360 |
Why?
|
| Infertility, Female | 3 | 2021 | 112 | 0.360 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 17 | 0.350 |
Why?
|
| Georgia | 6 | 2021 | 83 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 5 | 2024 | 1922 | 0.350 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2022 | 57 | 0.350 |
Why?
|
| Family Practice | 7 | 2017 | 404 | 0.340 |
Why?
|
| Cohort Studies | 7 | 2026 | 5982 | 0.340 |
Why?
|
| Postoperative Complications | 5 | 2026 | 2938 | 0.340 |
Why?
|
| Community-Based Participatory Research | 2 | 2025 | 166 | 0.340 |
Why?
|
| Africa | 3 | 2026 | 117 | 0.340 |
Why?
|
| Skin Diseases, Bacterial | 3 | 2016 | 22 | 0.330 |
Why?
|
| Rotator Cuff | 3 | 2009 | 59 | 0.320 |
Why?
|
| Mumps Vaccine | 3 | 2021 | 11 | 0.320 |
Why?
|
| Pertussis Vaccine | 3 | 2022 | 24 | 0.320 |
Why?
|
| Mental Health Services | 2 | 2026 | 474 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 1747 | 0.300 |
Why?
|
| Tenodesis | 1 | 2009 | 20 | 0.300 |
Why?
|
| Attitude | 3 | 2021 | 261 | 0.300 |
Why?
|
| Hospitalization | 9 | 2025 | 2443 | 0.290 |
Why?
|
| Australia | 4 | 2023 | 287 | 0.290 |
Why?
|
| Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.290 |
Why?
|
| Vaccines, Contraceptive | 1 | 2008 | 1 | 0.280 |
Why?
|
| Tendon Injuries | 1 | 2009 | 73 | 0.280 |
Why?
|
| Egg Proteins | 1 | 2008 | 20 | 0.280 |
Why?
|
| Hepatitis B virus | 2 | 2023 | 33 | 0.280 |
Why?
|
| Ovulation | 1 | 2008 | 41 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2464 | 0.280 |
Why?
|
| Guideline Adherence | 2 | 2013 | 589 | 0.270 |
Why?
|
| Ovarian Follicle | 1 | 2008 | 73 | 0.270 |
Why?
|
| Risk Factors | 10 | 2025 | 10816 | 0.260 |
Why?
|
| Skull Base | 2 | 2025 | 54 | 0.260 |
Why?
|
| California | 4 | 2026 | 475 | 0.260 |
Why?
|
| Cerebral Ventricles | 2 | 2025 | 54 | 0.260 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 168 | 0.260 |
Why?
|
| Child Health | 2 | 2019 | 158 | 0.250 |
Why?
|
| Professional-Family Relations | 3 | 2018 | 154 | 0.250 |
Why?
|
| Societies, Medical | 4 | 2019 | 893 | 0.250 |
Why?
|
| Maternal Health Services | 2 | 2019 | 102 | 0.250 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 138 | 0.250 |
Why?
|
| Mobile Applications | 2 | 2020 | 196 | 0.250 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2023 | 58 | 0.250 |
Why?
|
| Logistic Models | 3 | 2021 | 2119 | 0.240 |
Why?
|
| Databases, Factual | 4 | 2025 | 1488 | 0.240 |
Why?
|
| Data Collection | 3 | 2014 | 635 | 0.240 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 377 | 0.240 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2026 | 71 | 0.240 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2025 | 4 | 0.230 |
Why?
|
| Craniotomy | 1 | 2026 | 82 | 0.230 |
Why?
|
| Arthroplasty | 2 | 2003 | 59 | 0.230 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 501 | 0.230 |
Why?
|
| Early Ambulation | 1 | 2025 | 25 | 0.230 |
Why?
|
| Polyethylene | 1 | 2025 | 17 | 0.230 |
Why?
|
| Acetazolamide | 1 | 2025 | 26 | 0.220 |
Why?
|
| Pneumocephalus | 1 | 2025 | 5 | 0.220 |
Why?
|
| Child Care | 1 | 2025 | 36 | 0.220 |
Why?
|
| Blood Coagulation Factors | 1 | 2025 | 58 | 0.220 |
Why?
|
| Blood Transfusion | 2 | 2025 | 405 | 0.220 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2024 | 10 | 0.220 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2025 | 71 | 0.220 |
Why?
|
| Privacy | 1 | 2025 | 41 | 0.220 |
Why?
|
| Shoulder Joint | 2 | 2008 | 199 | 0.220 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2025 | 53 | 0.220 |
Why?
|
| Medically Underserved Area | 1 | 2025 | 101 | 0.220 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 148 | 0.220 |
Why?
|
| Craniosynostoses | 1 | 2025 | 68 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2025 | 120 | 0.210 |
Why?
|
| Haemophilus Vaccines | 1 | 2024 | 29 | 0.210 |
Why?
|
| Community Health Centers | 1 | 2024 | 59 | 0.210 |
Why?
|
| Syndrome | 1 | 2025 | 380 | 0.210 |
Why?
|
| Intracranial Hemorrhages | 1 | 2025 | 100 | 0.210 |
Why?
|
| Pregnancy Rate | 5 | 2023 | 69 | 0.210 |
Why?
|
| Astrocytoma | 1 | 2025 | 129 | 0.210 |
Why?
|
| Disease Management | 2 | 2025 | 647 | 0.210 |
Why?
|
| Time Factors | 4 | 2020 | 7186 | 0.210 |
Why?
|
| Acne Vulgaris | 1 | 2024 | 25 | 0.210 |
Why?
|
| Patellar Ligament | 1 | 2024 | 26 | 0.200 |
Why?
|
| Absenteeism | 1 | 2024 | 53 | 0.200 |
Why?
|
| Streptococcus agalactiae | 1 | 2025 | 109 | 0.200 |
Why?
|
| Orbit | 1 | 2024 | 65 | 0.200 |
Why?
|
| Home Health Aides | 1 | 2023 | 6 | 0.200 |
Why?
|
| Analgesics | 1 | 2026 | 231 | 0.200 |
Why?
|
| Tibia | 1 | 2025 | 176 | 0.200 |
Why?
|
| Empathy | 1 | 2026 | 182 | 0.200 |
Why?
|
| Seasons | 2 | 2020 | 557 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2025 | 357 | 0.200 |
Why?
|
| Stroke | 2 | 2025 | 1260 | 0.200 |
Why?
|
| Bacterial Vaccines | 1 | 2024 | 63 | 0.200 |
Why?
|
| Patient Education as Topic | 2 | 2019 | 782 | 0.200 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2024 | 85 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 1 | 2024 | 105 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 1 | 2025 | 90 | 0.200 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 70 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 276 | 0.200 |
Why?
|
| Nutritional Status | 1 | 2026 | 354 | 0.200 |
Why?
|
| Pituitary Neoplasms | 1 | 2025 | 190 | 0.190 |
Why?
|
| Prospective Studies | 5 | 2022 | 8011 | 0.190 |
Why?
|
| Perioperative Care | 1 | 2025 | 232 | 0.190 |
Why?
|
| Decision Making | 3 | 2020 | 980 | 0.190 |
Why?
|
| Audiometry, Evoked Response | 1 | 2022 | 15 | 0.190 |
Why?
|
| Silicone Elastomers | 1 | 2002 | 7 | 0.190 |
Why?
|
| Oxytocics | 1 | 2022 | 15 | 0.190 |
Why?
|
| Reoperation | 2 | 2025 | 631 | 0.190 |
Why?
|
| Gout | 1 | 2003 | 35 | 0.190 |
Why?
|
| Biological Transport | 1 | 2024 | 418 | 0.190 |
Why?
|
| Joint Prosthesis | 1 | 2002 | 22 | 0.190 |
Why?
|
| Frailty | 1 | 2026 | 200 | 0.190 |
Why?
|
| Hospitals | 3 | 2023 | 733 | 0.190 |
Why?
|
| Prostaglandins | 1 | 2022 | 94 | 0.190 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2024 | 137 | 0.180 |
Why?
|
| Suicidal Ideation | 2 | 2025 | 577 | 0.180 |
Why?
|
| Ovulation Induction | 2 | 2022 | 56 | 0.180 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2022 | 10 | 0.180 |
Why?
|
| Thumb | 1 | 2002 | 37 | 0.180 |
Why?
|
| Diagnostic Imaging | 1 | 2025 | 342 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2026 | 1894 | 0.180 |
Why?
|
| Cochlea | 1 | 2022 | 73 | 0.180 |
Why?
|
| Pain Management | 1 | 2026 | 407 | 0.180 |
Why?
|
| Rubella | 1 | 2022 | 22 | 0.180 |
Why?
|
| Algorithms | 3 | 2025 | 1846 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2025 | 662 | 0.180 |
Why?
|
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3613 | 0.180 |
Why?
|
| Orthopedic Procedures | 2 | 2023 | 243 | 0.180 |
Why?
|
| Infant Health | 1 | 2022 | 25 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2025 | 991 | 0.180 |
Why?
|
| Uterine Diseases | 1 | 2021 | 18 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2023 | 184 | 0.170 |
Why?
|
| Intrauterine Devices | 1 | 2021 | 29 | 0.170 |
Why?
|
| Russia | 1 | 2021 | 13 | 0.170 |
Why?
|
| Intention | 2 | 2020 | 187 | 0.170 |
Why?
|
| Fertilization in Vitro | 4 | 2023 | 92 | 0.170 |
Why?
|
| Live Birth | 4 | 2023 | 68 | 0.170 |
Why?
|
| Knee Injuries | 1 | 2022 | 122 | 0.170 |
Why?
|
| Automobile Driving | 1 | 2023 | 157 | 0.170 |
Why?
|
| Yellow Fever Vaccine | 2 | 2017 | 7 | 0.170 |
Why?
|
| Risk | 2 | 2015 | 912 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2020 | 1003 | 0.170 |
Why?
|
| Germany | 1 | 2021 | 138 | 0.170 |
Why?
|
| Demography | 2 | 2024 | 288 | 0.160 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 20 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2022 | 94 | 0.160 |
Why?
|
| General Practitioners | 1 | 2021 | 26 | 0.160 |
Why?
|
| Cluster Analysis | 2 | 2022 | 521 | 0.160 |
Why?
|
| Age Distribution | 1 | 2021 | 403 | 0.160 |
Why?
|
| Staphylococcal Infections | 1 | 2025 | 391 | 0.160 |
Why?
|
| Triage | 1 | 2023 | 249 | 0.160 |
Why?
|
| Ventriculostomy | 1 | 2000 | 24 | 0.160 |
Why?
|
| Antiviral Agents | 2 | 2023 | 768 | 0.160 |
Why?
|
| Cytokines | 2 | 2025 | 2066 | 0.160 |
Why?
|
| Internal Medicine | 2 | 2014 | 280 | 0.160 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2024 | 101 | 0.160 |
Why?
|
| Measles Vaccine | 1 | 2019 | 19 | 0.160 |
Why?
|
| Osteoarthritis | 1 | 2002 | 196 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 2541 | 0.150 |
Why?
|
| Drug Storage | 1 | 2020 | 53 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2024 | 376 | 0.150 |
Why?
|
| Norovirus | 1 | 2020 | 22 | 0.150 |
Why?
|
| Thrombosis | 1 | 2024 | 398 | 0.150 |
Why?
|
| Fever | 1 | 2021 | 312 | 0.150 |
Why?
|
| Eligibility Determination | 1 | 2020 | 72 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2018 | 1247 | 0.150 |
Why?
|
| Government Regulation | 1 | 2019 | 38 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 385 | 0.150 |
Why?
|
| State Government | 1 | 2019 | 46 | 0.150 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 99 | 0.150 |
Why?
|
| Reimbursement Mechanisms | 1 | 2020 | 80 | 0.150 |
Why?
|
| Pennsylvania | 1 | 2019 | 138 | 0.150 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 85 | 0.150 |
Why?
|
| Gastroenteritis | 1 | 2020 | 63 | 0.150 |
Why?
|
| Medicaid | 2 | 2021 | 466 | 0.150 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2017 | 97 | 0.150 |
Why?
|
| Motivation | 1 | 2024 | 612 | 0.140 |
Why?
|
| Therapeutic Uses | 1 | 2018 | 1 | 0.140 |
Why?
|
| Europe | 1 | 2020 | 416 | 0.140 |
Why?
|
| Morbidity | 1 | 2020 | 324 | 0.140 |
Why?
|
| Insemination, Artificial | 1 | 2018 | 11 | 0.140 |
Why?
|
| Clomiphene | 1 | 2018 | 15 | 0.140 |
Why?
|
| Fertility Agents, Female | 1 | 2018 | 21 | 0.140 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 383 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2019 | 125 | 0.140 |
Why?
|
| Melanoma | 1 | 2025 | 761 | 0.140 |
Why?
|
| Urban Health Services | 1 | 2018 | 71 | 0.140 |
Why?
|
| Machine Learning | 2 | 2025 | 589 | 0.140 |
Why?
|
| Smoking | 1 | 2025 | 1472 | 0.140 |
Why?
|
| Education, Continuing | 1 | 2018 | 41 | 0.140 |
Why?
|
| Hearing Loss, Sudden | 1 | 2018 | 11 | 0.130 |
Why?
|
| Nuclear Family | 1 | 2018 | 52 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 847 | 0.130 |
Why?
|
| Placentation | 1 | 2017 | 53 | 0.130 |
Why?
|
| Guatemala | 4 | 2020 | 346 | 0.130 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 238 | 0.130 |
Why?
|
| Trace Elements | 1 | 2017 | 52 | 0.130 |
Why?
|
| Cervical Plexus | 1 | 1997 | 2 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 266 | 0.130 |
Why?
|
| Altitude | 1 | 2021 | 473 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 73 | 0.130 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 81 | 0.130 |
Why?
|
| Quality Improvement | 3 | 2020 | 1296 | 0.130 |
Why?
|
| Rats | 1 | 2025 | 5616 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 1997 | 29 | 0.130 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 103 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1540 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2025 | 2439 | 0.120 |
Why?
|
| Morphogenesis | 1 | 2017 | 173 | 0.120 |
Why?
|
| Administrative Personnel | 1 | 2016 | 33 | 0.120 |
Why?
|
| Travel | 1 | 2017 | 136 | 0.120 |
Why?
|
| Physician Executives | 1 | 2016 | 28 | 0.120 |
Why?
|
| Allied Health Personnel | 1 | 2016 | 55 | 0.120 |
Why?
|
| Vaccines, Conjugate | 2 | 2018 | 60 | 0.120 |
Why?
|
| Telemedicine | 1 | 2025 | 957 | 0.120 |
Why?
|
| Cost of Illness | 2 | 2018 | 322 | 0.120 |
Why?
|
| Public Health Practice | 1 | 2016 | 63 | 0.120 |
Why?
|
| Diphtheria Toxoid | 1 | 2015 | 13 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2021 | 810 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2019 | 400 | 0.120 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 717 | 0.120 |
Why?
|
| Tetanus Toxoid | 1 | 2015 | 34 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2019 | 358 | 0.120 |
Why?
|
| Herpesvirus 3, Human | 1 | 2019 | 336 | 0.120 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 35 | 0.120 |
Why?
|
| Patient Participation | 1 | 2019 | 433 | 0.110 |
Why?
|
| Minority Groups | 1 | 2018 | 283 | 0.110 |
Why?
|
| Incidence | 2 | 2020 | 2892 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2018 | 180 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2019 | 299 | 0.110 |
Why?
|
| Curriculum | 1 | 2023 | 1072 | 0.110 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 80 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2018 | 369 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2017 | 223 | 0.110 |
Why?
|
| Focus Groups | 5 | 2018 | 579 | 0.110 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 169 | 0.110 |
Why?
|
| Cooperative Behavior | 3 | 2014 | 467 | 0.110 |
Why?
|
| Mutation | 1 | 2026 | 4104 | 0.110 |
Why?
|
| Leadership | 1 | 2019 | 410 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4580 | 0.110 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 1104 | 0.110 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2017 | 247 | 0.110 |
Why?
|
| Occupational Health Services | 1 | 2014 | 37 | 0.110 |
Why?
|
| Zinc | 1 | 2017 | 296 | 0.110 |
Why?
|
| Neck Pain | 1 | 2014 | 30 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2021 | 790 | 0.110 |
Why?
|
| Acute Disease | 4 | 2025 | 1031 | 0.110 |
Why?
|
| Prevalence | 1 | 2021 | 2838 | 0.100 |
Why?
|
| Poverty | 1 | 2018 | 530 | 0.100 |
Why?
|
| Nurses | 1 | 2016 | 180 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 38177 | 0.100 |
Why?
|
| Public Health Administration | 1 | 2014 | 73 | 0.100 |
Why?
|
| State Medicine | 2 | 2024 | 27 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2018 | 492 | 0.100 |
Why?
|
| Circovirus | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2182 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 288 | 0.100 |
Why?
|
| Intussusception | 1 | 2013 | 25 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 501 | 0.090 |
Why?
|
| Drug Contamination | 1 | 2013 | 52 | 0.090 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 73 | 0.090 |
Why?
|
| Serogroup | 2 | 2025 | 44 | 0.090 |
Why?
|
| Clinical Decision-Making | 3 | 2021 | 360 | 0.090 |
Why?
|
| Fertilization | 2 | 2023 | 44 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2017 | 1122 | 0.090 |
Why?
|
| Workplace | 1 | 2014 | 274 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 270 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 2945 | 0.090 |
Why?
|
| Obesity | 1 | 2025 | 3085 | 0.090 |
Why?
|
| Neisseria meningitidis | 1 | 2011 | 23 | 0.090 |
Why?
|
| Professional Practice Location | 1 | 2011 | 26 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5431 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2016 | 589 | 0.090 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 101 | 0.090 |
Why?
|
| Outpatients | 1 | 2015 | 443 | 0.080 |
Why?
|
| Perinatal Care | 1 | 2012 | 62 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2019 | 1177 | 0.080 |
Why?
|
| Placenta | 1 | 2017 | 781 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 1992 | 0.080 |
Why?
|
| Birth Rate | 2 | 2022 | 28 | 0.080 |
Why?
|
| Prognosis | 3 | 2026 | 4310 | 0.080 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2010 | 47 | 0.080 |
Why?
|
| Swine | 1 | 2013 | 835 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2012 | 555 | 0.080 |
Why?
|
| Hospices | 1 | 2011 | 89 | 0.080 |
Why?
|
| Sports | 1 | 2012 | 212 | 0.080 |
Why?
|
| Quality of Life | 3 | 2024 | 3197 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1271 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 2592 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 441 | 0.070 |
Why?
|
| Rotator Cuff Injuries | 1 | 2009 | 79 | 0.070 |
Why?
|
| Neuromuscular Diseases | 1 | 2011 | 146 | 0.070 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.070 |
Why?
|
| Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Communicable Diseases | 2 | 2022 | 163 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 36 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2008 | 125 | 0.070 |
Why?
|
| Appointments and Schedules | 2 | 2019 | 98 | 0.060 |
Why?
|
| Cell Phone | 2 | 2019 | 82 | 0.060 |
Why?
|
| Tendons | 1 | 2008 | 129 | 0.060 |
Why?
|
| Leukocytes | 1 | 2008 | 295 | 0.060 |
Why?
|
| Ovary | 1 | 2008 | 228 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2026 | 3686 | 0.060 |
Why?
|
| Health Surveys | 2 | 2018 | 518 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 1253 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2026 | 147 | 0.060 |
Why?
|
| Sphenoid Sinus | 1 | 2025 | 7 | 0.060 |
Why?
|
| Neoplasm Grading | 1 | 2026 | 310 | 0.060 |
Why?
|
| Sphenoid Bone | 1 | 2025 | 15 | 0.060 |
Why?
|
| Central Nervous System Cysts | 1 | 2025 | 13 | 0.060 |
Why?
|
| Fetal Development | 1 | 2008 | 299 | 0.060 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 112 | 0.050 |
Why?
|
| Tranexamic Acid | 1 | 2025 | 53 | 0.050 |
Why?
|
| Antifibrinolytic Agents | 1 | 2025 | 62 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2025 | 100 | 0.050 |
Why?
|
| Immobilization | 1 | 2004 | 53 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 530 | 0.050 |
Why?
|
| Tetracyclines | 1 | 2024 | 17 | 0.050 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2024 | 44 | 0.050 |
Why?
|
| Smallpox Vaccine | 1 | 2024 | 23 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2024 | 115 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2024 | 122 | 0.050 |
Why?
|
| Shoulder Dislocation | 1 | 2004 | 61 | 0.050 |
Why?
|
| Palivizumab | 1 | 2023 | 11 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2025 | 221 | 0.050 |
Why?
|
| Acromion | 1 | 2003 | 8 | 0.050 |
Why?
|
| Ligaments | 1 | 2024 | 75 | 0.050 |
Why?
|
| National Health Programs | 1 | 2023 | 23 | 0.050 |
Why?
|
| Adenoma | 1 | 2025 | 218 | 0.050 |
Why?
|
| Labor, Induced | 1 | 2022 | 40 | 0.050 |
Why?
|
| Health Services | 1 | 2023 | 115 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 96 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 75 | 0.050 |
Why?
|
| Neoplasms | 1 | 2018 | 2887 | 0.050 |
Why?
|
| Term Birth | 1 | 2022 | 25 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2745 | 0.050 |
Why?
|
| Joint Instability | 1 | 2024 | 183 | 0.040 |
Why?
|
| Sheep | 1 | 2024 | 880 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 28 | 0.040 |
Why?
|
| Hysteroscopy | 1 | 2021 | 13 | 0.040 |
Why?
|
| Hand Strength | 1 | 2002 | 144 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 851 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2025 | 250 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 34 | 0.040 |
Why?
|
| Psychiatric Nursing | 1 | 2001 | 10 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 893 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2001 | 64 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2001 | 79 | 0.040 |
Why?
|
| Multigene Family | 1 | 2001 | 207 | 0.040 |
Why?
|
| Cadaver | 2 | 2004 | 307 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 2001 | 30 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2025 | 1103 | 0.040 |
Why?
|
| Vaccines, Inactivated | 1 | 2021 | 70 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2026 | 2118 | 0.040 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2020 | 43 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2001 | 66 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2020 | 36 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2021 | 129 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2000 | 43 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2008 | 1746 | 0.040 |
Why?
|
| Lateral Ventricles | 1 | 2000 | 32 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2019 | 22 | 0.040 |
Why?
|
| Social Networking | 1 | 2020 | 37 | 0.040 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 134 | 0.040 |
Why?
|
| Inpatients | 1 | 2024 | 551 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2001 | 286 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 210 | 0.040 |
Why?
|
| Catheterization | 1 | 2000 | 183 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2023 | 438 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 126 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2003 | 770 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2001 | 158 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 411 | 0.030 |
Why?
|
| Knee Joint | 1 | 2022 | 427 | 0.030 |
Why?
|
| Equipment Design | 1 | 2000 | 530 | 0.030 |
Why?
|
| Pharmacists | 1 | 2021 | 240 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2025 | 987 | 0.030 |
Why?
|
| Family | 1 | 2022 | 682 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2001 | 260 | 0.030 |
Why?
|
| Awareness | 1 | 2018 | 110 | 0.030 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 28 | 0.030 |
Why?
|
| Heart Rate | 1 | 2001 | 857 | 0.030 |
Why?
|
| Educational Status | 1 | 2019 | 467 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2026 | 1145 | 0.030 |
Why?
|
| Accessory Nerve | 1 | 1997 | 4 | 0.030 |
Why?
|
| Internationality | 1 | 2018 | 156 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 3172 | 0.030 |
Why?
|
| Patients | 1 | 2018 | 182 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 141 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 220 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 18394 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2001 | 986 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2018 | 243 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2025 | 1173 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2018 | 140 | 0.030 |
Why?
|
| Self Report | 1 | 2020 | 873 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1311 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 582 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 480 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 706 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 365 | 0.030 |
Why?
|
| Ergonomics | 1 | 2014 | 29 | 0.030 |
Why?
|
| Prescriptions | 1 | 2014 | 76 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2014 | 46 | 0.030 |
Why?
|
| Efficiency | 1 | 2014 | 104 | 0.030 |
Why?
|
| Abscess | 1 | 2014 | 75 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 460 | 0.030 |
Why?
|
| Wound Infection | 1 | 2014 | 57 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2018 | 949 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2024 | 2333 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 2115 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 2959 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2014 | 129 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 2371 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 199 | 0.020 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2011 | 78 | 0.020 |
Why?
|
| Diet | 1 | 2017 | 1285 | 0.020 |
Why?
|
| Biomechanical Phenomena | 2 | 2004 | 845 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 853 | 0.020 |
Why?
|
| Exercise | 2 | 2014 | 2206 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2926 | 0.020 |
Why?
|
| Rotation | 1 | 2004 | 121 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 196 | 0.010 |
Why?
|
| Palliative Care | 1 | 2011 | 1012 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 424 | 0.010 |
Why?
|
| Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
|
| Nursing Methodology Research | 1 | 2001 | 47 | 0.010 |
Why?
|
| Helping Behavior | 1 | 2001 | 20 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2001 | 249 | 0.010 |
Why?
|
| Chromium Alloys | 1 | 2000 | 4 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 510 | 0.010 |
Why?
|
| Psychological Theory | 1 | 2001 | 93 | 0.010 |
Why?
|
| Durapatite | 1 | 2000 | 36 | 0.010 |
Why?
|
| Bone Cements | 1 | 2000 | 39 | 0.010 |
Why?
|
| Porosity | 1 | 2000 | 96 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2000 | 65 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 1386 | 0.010 |
Why?
|
| Social Support | 1 | 2001 | 652 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2001 | 2152 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2001 | 1153 | 0.010 |
Why?
|